Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

A Proinflammatory Invariant Natural Killer T Cells Phenotypic State Associates with Human Graft-Versus-Host Disease Onset and Response

Tom Erkers, PhD, Bryan Xei, BS, Laura Kenyon, Mary Rieck, BS, Marina Basina, MD, Kent Jensen, PhD, Samuel Strober, MD, Robert S. Negrin, MD, Holden T. Maecker, PhD, Everett H Meyer, MD PhD

Blood (2018) 132 (Supplement 1): 2111.

https://doi.org/10.1182/blood-2018-99-120358

Published: 2018

Journal Articles

Nonmyeloablative Allogeneic Transplantation Using TLI-ATG Conditioning for Lymphoid and Myeloid Malignancies: Mature Follow-up from a Large, Single Institution Cohort

Michael A Spinner, MD, Vanessa E Kennedy, MD, John S Tamaresis, PhD, Philip W Lavori, PhD, Linda V Elder, BA, Sally Arai, MD, Laura J Johnston, MD, Everett H Meyer, MD PhD, David B. Miklos, MD PhD, Lori S Muffly, MD, Robert S. Negrin, MD, Andrew R Rezvani, MD, Judith A Shizuru, MD PhD, Wen-Kai Weng, MD PhD, Richard T Hoppe, MD, Samuel Strober, MD, Robert Lowsky, MD

Blood (2018) 132 (Supplement 1): 4638.

https://doi.org/10.1182/blood-2018-99-113597

Published: 2018

Journal Articles

Consolidative CD8 + Memory T-Cell Donor Lymphocyte Infusion Augments Donor Chimerism with a Low Risk of Gvhd Following Matched Related Donor Hematopoietic Cell Transplantation

Michael A. Spinner, MD, Lori S. Muffly, MD MS, Sally Arai, MD, Laura Johnston, MD, Everett H. Meyer, MD PhD, David B. Miklos, MD PhD, Robert S. Negrin, MD, Andrew R. Rezvani, MD, Judith A. Shizuru, MD PhD, Wen-Kai Weng, MD PhD, Samuel Strober, MD, Robert Lowsky, MD

Blood (2017) 130 (Supplement 1): 2003.

https://doi.org/10.1182/blood.V130.Suppl_1.2003.2003

Published: 2017

Journal Articles

Allogeneic Transplants from HLA-Mismatched Unrelated Donors Using Total Lymphoid Irradiation and Antithymocyte Globulin Conditioning Retain a Low Risk of Graft-Versus-Host Disease and Non-Relapse Mortality with at Least As Potent Anti-Tumor Activity As with Matched Unrelated Donors

Michael A. Spinner, MD, Marcelo Fernandez Vina, PhD, Linda Elder, BA, Sally Arai, MD, Laura Johnston, MD, Everett Meyer, MD PhD, David Miklos, MD PhD, Lori Muffly, MD, Robert S. Negrin, MD, Judith Shizuru, MD PhD, Wen-Kai Weng, MD PhD, Ginna G. Laport, MD, Samuel Strober, MD, Robert Lowsky, MD, Andrew R. Rezvani, MD

Blood (2016) 128 (22): 4669.

https://doi.org/10.1182/blood.V128.22.4669.4669

Published: 2016

Journal Articles

Donor-Derived CIK Cell Infusion As Consolidative Therapy after Non-Myeloablative Allogeneic Transplant in Patients with Myeloid Neoplasms

Blood (2015) 126 (23): 3232.

https://doi.org/10.1182/blood.V126.23.3232.3232

Published: 2015

Journal Articles

Identification of Candidate Transcriptional Biomarkers Associated with Chronic Graft-Versus-Host Disease Following Allogeneic Hematopoietic Cell Transplantation

Holbrook E Kohrt, MD, PhD, Lu Tian, PhD, Li Li, PhD, Ash A. Alizadeh, MD, PhD, Sue Hsieh, PhD, Samuel Strober, MD, Minnie Sarwal, MD PhD, Robert Lowsky, MD

Blood (2012) 120 (21): 4190.

https://doi.org/10.1182/blood.V120.21.4190.4190

Published: 2012

Journal Articles

Donor Immunization with WT1 Peptide Augments Anti-Leukemic Activity After MHC-Matched Bone Marrow Transplantation

Holbrook E Kohrt, MD, Antonia MS Mueller, MD, Jeanette B Baker, PhD, Matthew J Goldstein, PhD, Evan Newell, PhD, Suparna Dutt, PhD, Debra K Czerwinski, Robert Lowsky, MD, Samuel Strober, MD

Blood (2011) 118 (21): 1896.

https://doi.org/10.1182/blood.V118.21.1896.1896

Published: 2011

Journal Articles

Noninvasive Prediction of Graft-Verus-Host Disease Following Allogeneic Hematopoietic Cell Transplantation by Gene Expression Profiling

Holbrook E Kohrt, MD, Li Li, PhD, Ash A Alizadeh, MD/PhD, Matthew J Goldstein, MD, Samuel Strober, MD, Minnie Sarwal, MD/PhD, Robert Lowsky, MD

Blood (2010) 116 (21): 896.

https://doi.org/10.1182/blood.V116.21.896.896

Published: 2010

Journal Articles

Allosensitized Memory CD4 T Cells Induce Chronic Graft Versus Host Disease.

Suparna Dutt, PhD, Diane Tseng, BS, Tracy I. George, MD, Joerg Ermann, MD, Yinping Liu, MS, C. Garrison Fathman, MD, Samuel Strober, MD

Blood (2006) 108 (11): 449.

https://doi.org/10.1182/blood.V108.11.449.449

Published: 2006

Journal Articles

Clinical Outcomes Following Allogeneic Hematopoietic Cell Transplantation (HCT) Using Nonmyeloablative Host Conditioning with Total Lymphoid Irradiation and Anti-Thymocyte Globulin Confirm a Low Incidence of Graft Versus Host Disease (GVHD) and Retained Graft Anti-Tumor Activity.

Robert Lowsky, MD, Keith Stockerl-Goldstein, MD, Ginna Laport, MD, David Miklos, MD, Sally Arai, MD, Judith Shizuru, MD, Laura Johnston, MD, Karl Blume, MD, Robert Negrin, MD, Samuel Strober, MD

Blood (2006) 108 (11): 603.

https://doi.org/10.1182/blood.V108.11.603.603

Published: 2006

Journal Articles

Mechanisms by Which NK T Cells Become the Predominant T Cell Subset in Mice after Irradiation.

Zhenyu Yao, MD, PhD, Yinping Liu, MD, Jennifer McIntire, MD, PhD, Samuel Strober, MD

Blood (2005) 106 (11): 4295.

https://doi.org/10.1182/blood.V106.11.4295.4295

Published: 2005

Journal Articles

Memory CD4 T Cells Induce Graft Versus Host Disease.

Suparna Dutt, PhD, Diane Tseng, Joerg Ermann, MD, Yin Ping Liu, MD, Tracy I. George, MD, C. Garrison Fathman, MD, Samuel Strober, MD

Blood (2005) 106 (11): 1309.

https://doi.org/10.1182/blood.V106.11.1309.1309

Published: 2005

Journal Articles

Donor CD4 + T and B Cells in Transplants Induce Autoimmune-Like Chronic Graft Versus Host Disease.

Chunyan Zhang, MD, PhD, Ivan Todorov, PhD, Zhifang Zhang, MD, PhD, Yinping Liu, MD, Fouad Kandeel, MD, PhD, Stephen Forman, MD, Samuel Strober, MD, Defu Zeng, MD

Blood (2005) 106 (11): 1313.

https://doi.org/10.1182/blood.V106.11.1313.1313

Published: 2005

Journal Articles

Protection Against Graft-Versus-Host Disease and Retention of Graft-Versus-Tumor Effect after Allogeneic BMT in Mice Conditioned with TLI and Anti-Thymocyte Serum.

Asha Pillai, MD, Pearline Teo, BS, Samuel Strober, MD

Blood (2004) 104 (11): 3049.

https://doi.org/10.1182/blood.V104.11.3049.3049

Published: 2004

Journal Articles

Donor CD8+ T Cells Facilitate Graft-Versus-Tumor Effect Via Alloantigen Rather Than Tumor-Specific Antigen Recognition Following Murine Myeloablative BMT.

Asha B. Pillai, MD, Pearline A. Teo, BS, Aditi Mukhopadhyay, BS, Samuel Strober, MD

Blood (2004) 104 (11): 3051.

https://doi.org/10.1182/blood.V104.11.3051.3051

Published: 2004

Journal Articles

The Transcription Factor Pbx1 Is Required for the Development of Double Positive Thymic T Cells.

Mrinmoy Sanyal, PhD, James W. Tung, PhD, Sussan Dejbakhsh-Jones, PhD, Samuel Strober, MD, Leonore A. Herzenberg, PhD, Michael L. Cleary, MD

Blood (2004) 104 (11): 2771.

https://doi.org/10.1182/blood.V104.11.2771.2771

Published: 2004

Journal Articles

Non-Myeloablative Conditioning of Total Lymphoid Irradiation (TLI) and Anti-Thymocyte Globulin (ATG) Protects Against Acute GVHD Following Allogeneic Hematopoietic Cell Transplantation (HCT) but Retains Anti-Tumor Activity.

Robert Lowsky, MD, Tsuyoshi Takahashi, MD, Yin Ping, MD, Judith Shizuru, MD, PhD, Robert S. Negrin, MD, Samuel Strober, MD

Blood (2004) 104 (11): 433.

https://doi.org/10.1182/blood.V104.11.433.433

Published: 2004

NARROW

A Proinflammatory Invariant Natural Killer T Cells Phenotypic State Associates with Human Graft-Versus-Host Disease Onset and Response

Nonmyeloablative Allogeneic Transplantation Using TLI-ATG Conditioning for Lymphoid and Myeloid Malignancies: Mature Follow-up from a Large, Single Institution Cohort

Consolidative CD8 + Memory T-Cell Donor Lymphocyte Infusion Augments Donor Chimerism with a Low Risk of Gvhd Following Matched Related Donor Hematopoietic Cell Transplantation

Allogeneic Transplants from HLA-Mismatched Unrelated Donors Using Total Lymphoid Irradiation and Antithymocyte Globulin Conditioning Retain a Low Risk of Graft-Versus-Host Disease and Non-Relapse Mortality with at Least As Potent Anti-Tumor Activity As with Matched Unrelated Donors

Donor-Derived CIK Cell Infusion As Consolidative Therapy after Non-Myeloablative Allogeneic Transplant in Patients with Myeloid Neoplasms

Identification of Candidate Transcriptional Biomarkers Associated with Chronic Graft-Versus-Host Disease Following Allogeneic Hematopoietic Cell Transplantation

Donor Immunization with WT1 Peptide Augments Anti-Leukemic Activity After MHC-Matched Bone Marrow Transplantation

Noninvasive Prediction of Graft-Verus-Host Disease Following Allogeneic Hematopoietic Cell Transplantation by Gene Expression Profiling

Allosensitized Memory CD4 T Cells Induce Chronic Graft Versus Host Disease.

Clinical Outcomes Following Allogeneic Hematopoietic Cell Transplantation (HCT) Using Nonmyeloablative Host Conditioning with Total Lymphoid Irradiation and Anti-Thymocyte Globulin Confirm a Low Incidence of Graft Versus Host Disease (GVHD) and Retained Graft Anti-Tumor Activity.

Mechanisms by Which NK T Cells Become the Predominant T Cell Subset in Mice after Irradiation.

Memory CD4 T Cells Induce Graft Versus Host Disease.

Donor CD4 + T and B Cells in Transplants Induce Autoimmune-Like Chronic Graft Versus Host Disease.

Protection Against Graft-Versus-Host Disease and Retention of Graft-Versus-Tumor Effect after Allogeneic BMT in Mice Conditioned with TLI and Anti-Thymocyte Serum.

Donor CD8+ T Cells Facilitate Graft-Versus-Tumor Effect Via Alloantigen Rather Than Tumor-Specific Antigen Recognition Following Murine Myeloablative BMT.

The Transcription Factor Pbx1 Is Required for the Development of Double Positive Thymic T Cells.

Non-Myeloablative Conditioning of Total Lymphoid Irradiation (TLI) and Anti-Thymocyte Globulin (ATG) Protects Against Acute GVHD Following Allogeneic Hematopoietic Cell Transplantation (HCT) but Retains Anti-Tumor Activity.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only